The DOI matches its Crossref record; 52 of the 52 references it cites were found in a registry or an index.
A Mixture of trans-Galactooligosaccharides Reduces Markers of Metabolic Syndrome and Modulates the Fecal Microbiota and Immune Function of Overweight Adults
Open accessAbstract
Metabolic syndrome is a set of disorders that increases the risk of developing cardiovascular disease. The gut microbiota is altered toward a less beneficial composition in overweight adults and this change can be accompanied by inflammation. Prebiotics such as galactooligosaccharides can positively modify the gut microbiota and immune system; some may also reduce blood lipids. We assessed the effect of a galactooligosaccharide mixture [Bi2muno (B-GOS)] on markers of metabolic syndrome, gut microbiota, and immune function in 45 overweight adults with ≥3 risk factors associated with metabolic syndrome in a double-blind, randomized, placebo (maltodextrin)-controlled, crossover study (with a 4-wk wash-out period between interventions). Whole blood, saliva, feces, and anthropometric measurements were taken at the beginning, wk 6, and end of each 12-wk intervention period. Predominant groups of fecal bacteria were quantified and full blood count, markers of inflammation and lipid metabolism, insulin, and glucose were measured. B-GOS increased the number of fecal bifidobacteria at the expense of less desirable groups of bacteria. Increases in fecal secretory IgA and decreases in fecal calprotectin, plasma C-reactive protein, insulin, total cholesterol (TC), TG, and the TC:HDL cholesterol ratio were also observed. Administration of B-GOS to overweight adults resulted in positive effects on the composition of the gut microbiota, the immune response, and insulin, TC, and TG concentrations. B-GOS may be a useful candidate for the enhancement of gastrointestinal health, immune function, and the reduction of metabolic syndrome risk factors in overweight adults.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
An obesity-associated gut microbiome with increased capacity for energy harvest
Turnbaugh, P. J., Ley, R. E., Mahowald, M. A., Magrini, V., Mardis, E. R., & Gordon, J. I. (2006) · Nature · doi:10.1038/nature05414 · Cited by 12,444
Inflammation and metabolic disorders
Hotamisligil, G. S. (2006) · Nature · doi:10.1038/nature05485 · Cited by 9,199
Dietary Modulation of the Human Colonic Microbiota: Introducing the Concept of Prebiotics
Gibson, G. R., & Roberfroid, M. B. (1995) · Journal of Nutrition · doi:10.1093/jn/125.6.1401 · Cited by 7,659
Self-citationMetabolic Endotoxemia Initiates Obesity and Insulin Resistance
Cani, P. D., Amar, J., Iglesias, M. A., Poggi, M., Knauf, C., Bastelica, D., Neyrinck, A. M., Fava, F., Tuohy, K. M., Chabo, C., et al. (2007) · Diabetes · doi:10.2337/db06-1491 · Cited by 6,638
Self-citationEckel, R. H., Alberti, K., Grundy, S. M., & Zimmet, P. (2010) · The Lancet · doi:10.1016/s0140-6736(09)61794-3 · Cited by 6,317
The gut microbiota as an environmental factor that regulates fat storage
Bäckhed, F., Ding, H., Wang, T., Hooper, L. V., Koh, G. Y., Nagy, A., Semenkovich, C. F., & Gordon, J. I. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0407076101 · Cited by 6,245
Obesity alters gut microbial ecology
Ley, R. E., Bäckhed, F., Turnbaugh, P., Lozupone, C. A., Knight, R. D., & Gordon, J. I. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0504978102 · Cited by 6,176
Turnbaugh, P. J., Ley, R. E., Hamady, M., Fraser-Liggett, C. M., Knight, R., & Gordon, J. I. (2007) · Nature · doi:10.1038/nature06244 · Cited by 6,091
Eckel, R. H., Grundy, S. M., & Zimmet, P. (2005) · The Lancet · doi:10.1016/s0140-6736(05)66378-7 · Cited by 5,755
Cani, P. D., Bibiloni, R., Knauf, C., Waget, A., Neyrinck, A. M., Delzenne, N. M., & Burcelin, R. (2008) · Diabetes · doi:10.2337/db07-1403 · Cited by 4,819
Flagged first, then by citations
Cited by
Sorted by citations
Items 301–349 of 349
Uebel, G. C., Schlickmann, D. D. S., Eisenhardt, M. M., Renner, J. D. P., & Coitinho, A. S. (2023) · Revista Contemporânea · doi:10.56083/rcv3n12-093 · Cited by 1
Fermentable Carbohydrate Intake and Differences in Health Parameters in US College Students
Navrkal, B. (2015) · doi:10.23860/thesis-navrkal-brittany-2015 · Cited by 1
The gut in control of health and disease
van der Beek (2017) · Research Publications (Maastricht University) · doi:10.26481/dis.20171004cvdb · Cited by 1
Prebiotic Oligosaccharide Production in Microbial Cells
Jaswal, A. S., Mishra, S., & Elangovan, R. (2025) · doi:10.1002/9781394241538.ch5 · Cited by 1
WOOD BIOCHEMICALS FOR THE PROTECTION OF HEALTH FOCUS ON HEMICELLULOSE, STILBENOIDS AND LIGNANS
Polari, L. (2015) · UTUPub (University of Turku)
Al-Hamedi, O., Hoffmann, L., Capocci, M., Riley, M., Viswanathan, U., Walters, A. L., Reynell, J., Scallan, T., Stephen, M., Kotecha, R., et al. (2013)
Effects of Brassica on the human gut microbiota
Kellingray, L. (2015) · UEA Digital Repository (University of East Anglia)
Dietary Manipulation of Gut Microbiota for Improvement of Metabolic Health
Bomhof, M. R. (2016) · Libraries and Cultural Resources (University of Calgary) · doi:10.11575/prism/25704
Galactooligosaccharides and substrate and energy metabolism, dietary intake and body composition
Dijck, V. M. A. J. (2016) · MaRBLe · doi:10.26481/marble.2015.v6.382
Villanueva, E. M. G. D. P. (2018) · RiuNet (Universitat Politècnica de València) · doi:10.4995/thesis/10251/114770
Murtaza, N. (2020) · The University of Queensland · doi:10.14264/uql.2020.151
Prebiotic Dietary Fibers: Evaluation Of Fermentability And Prebiotic Potential
Erickson, J. M. (2018) · University of Minnesota Digital Conservancy (University of Minnesota)
Guidelines for the clinical use of probiotics' and its limited value for gastrointestinal disorders
Hassan, K., Alahmari, A., Alfaifi, O. M. A., Alshehri, A., Alqhtani, A. S., Bagais, R., Mesawa, O. T., Alzahrani, B. A., K.Al-Senan, A., Ashi, R. T., et al. (2020) · International Journal of Community Medicine and Public Health · doi:10.18203/2394-6040.ijcmph20204014
Mathanghi, S. K. (2020) · emergent Life Sciences Research · doi:10.31783/elsr.2020.626773
Modulating the immune system and intestinal barrier integrity with functional oligosaccharides
Figueroa‐Lozano, S. (2021) · University of Groningen research database (University of Groningen / Centre for Information Technology) · doi:10.33612/diss.151659844
Gut microbiota and metabolic diseases
Guiteras, C. G. (2021) · Dipòsit Digital de la Universitat de Barcelona (Universitat de Barcelona)
Obesity, Metabolic Syndrome and Inflammation
Lee, J. (2021) · Springer eBooks · doi:10.1007/978-3-030-86684-6_7
Argentina: licencias de Uso No Propietarias: Software Libre y Software de Código Abierto
Iglesias, G. (2008) · Hispana
(2018) · Wiley eBooks · doi:10.1002/9781118829875.refs
Microbiota, obesity and insulin resistance
Reijnders, D. (2016) · Research Publications (Maastricht University) · doi:10.26481/dis.20160921dr
Jadhav, A. (2021) · Digital Commons - URI (University of Rhode Island) · doi:10.23860/diss-jadhav-ajita-2021
Impact of Probiotic and Prebiotic on Gut Microbiota in Pre-diabetes and Type 2 Diabetes
Ramos, F. M. M., Salgaço, M. K., Cesar, T. B., & Sivieri, K. (2022) · Springer eBooks · doi:10.1007/978-3-030-92196-5_3
HUMAN GUT MICROBIOTA AND ITS EFFECTS ON HUMAN HEALTH IN NORMAL AND PATHOLOGICAL CONDITIONS
Munteanu, A. M., Cursaru, R., Guja, L., Carniciu, S., Borcan, A. M., & Popescu‐Spineni, D. (2017) · Romanian Medical Journal · doi:10.37897/rmj.2017.3.2
Impact of gut-derived metabollites on substrate metabolism and metabolic health
Gonzalez Hernandez Manuel, A. (2020) · Research Publications (Maastricht University) · doi:10.26481/dis.20201027mgh
The etiology of gut dysbiosis and its role in chronic disease
Danenberg, A. H. (2022) · Elsevier eBooks · doi:10.1016/b978-0-12-822238-6.00020-0
A food-grade nanoemulsion for delivering probiotics and prebiotics
Duraisamy, S., Balakrishnan, S., Raju, A., Prahalathan, C., & Kumarasamy, A. (2022) · Elsevier eBooks · doi:10.1016/b978-0-323-89846-1.00003-6
Seed-extracted mucilages: Galactomannan
Yang, J., & Tan, H. (2025) · Elsevier eBooks · doi:10.1016/b978-0-443-21630-5.00006-x
Jadhav, A., Vadiveloo, M. K., Laforge, R. G., & Melanson, K. J. (2025) · Journal of American College Health · doi:10.1080/07448481.2025.2475309
Киселева, Т. Л., Киселева, М. А., & Хлебников, Е. В. (2025) · Традиционная медицина · doi:10.54296/18186173_2025_1_15
Chen, W., Wang, S., Xu, Q., Zhang, H., Yang, M., Zhang, L., & Sun, D. (2026) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.5c14630
Tian, L., Lin, Y., Yue, P., Gao, L., Wang, L., Huang, C., Zhao, J., Jiang, N., Xi, J., Ma, H., et al. (2026) · iMetaMed · doi:10.1002/imm3.70029 · Cited by 1
Armah, J., Alzahid, S., Pei, Q., Cousin, L., Fanfan, D., Heldermon, C. D., & Lyon, D. (2026) · Oncoscience · doi:10.18632/oncoscience.651
Fahim, S. M., Miah, M., Marcotte, M., Zoria, N., Ahmed, M., Huey, S., Erickson, D., Finkelstein, J. L., & Mehta, S. (2026) · Advances in Nutrition · doi:10.1016/j.advnut.2026.100625
Bedu-Ferrari, C. (2022) · theses.fr (ABES) · doi:10.70675/17cf5e69z9e36z4daczb0b6z93f0767b79db
Macůrková, A., Bleha, R., Synytsya, A., Krausová, G., Štětina, J., Němečková, I., & Čurda, L. (2026) · SSRN Electronic Journal · doi:10.2139/ssrn.6591045
Biotics: The Food Ingredients Supporting the Intestinal Microbiota and Immune System in Psoriasis
Biasi, J. D., Giménez‐Bastida, J. A., & Krupa‐Kozak, U. (2026) · Nutrition Reviews · doi:10.1093/nutrit/nuaf252
Macůrková, A., Bleha, R., Synytsya, A., Krausová, G., Štětina, J., Němečková, I., & Čurda, L. (2026) · Carbohydrate Research · doi:10.1016/j.carres.2026.110023
Rueda-Escalona, A. A., Palazuelos-Altamirano, F., Zaldívar-Díaz, P., Landa-Esquivias, B., Jiménez-García, A. M., Castro-Eguiluz, D., & Contreras, O. M. (2026) · Nutraceuticals · doi:10.3390/nutraceuticals6030047
Microbiome and atherosclerosis: hype or future therapeutic target?
Hussain, Z., Gali, M., Patel, D., Kumar, A. S., Kumar, A. S., Ranganatha, A., & Swathi, N. L. (2026) · Journal of Basic and Clinical Physiology and Pharmacology · doi:10.1515/jbcpp-2025-0190
β-Galactosidase: From Lactose Hydrolysis to Glycosylation Engineering
Wei, W., & Guo, J. (2026) · Engineering Microbiology · doi:10.1016/j.engmic.2026.100306
Disease-specific glycosylation in the neurodegenerative brain
Edwards, M., Vassileff, N., Steinert, J. R., & Spiers, J. G. (2026) · Elsevier eBooks · doi:10.1016/b978-0-443-34176-2.00015-8
Jaegher, S. D., Podrini, C., D’Aguanno, M., Santoro, F., & Biazzo, M. (2026) · Frontiers in Microbiology · doi:10.3389/fmicb.2026.1949973
Sage, S. A., Abbott, S. J., Korczak, R., & Williams, N. C. (2026) · Journal of the International Society of Sports Nutrition · doi:10.1080/15502783.2026.2748763
Bajwa, A. A., Iqbal, S., Nasir, M., & Anjum, A. A. (2026) · AIMS Medical Science · doi:10.3934/medsci.2026016
Miklusiak, K. D., Komorniak, N., Wrońska, K., Niedolistek, J., Zawada, W., Szewczyk, K., & Stachowska, E. (2026) · Food Bioscience · doi:10.1016/j.fbio.2026.110339
Metadata
- Authors
- Vulevic, J., Juric, A., Tzortzis, G., & Gibson, G. R.
- Affiliations
- University of Reading (GB)
- Corresponding author
- Vulevic, Jelena
- Venue
- The Journal of Nutrition
- Publisher
- Elsevier BV
- Published
- 2013-03
- Volume
- 143
- Issue
- 3
- Pages
- 324-331
- ISSN
- 0022-3166 (ISSN-L)
- OpenAlex
- W2145232186
- Cited by
- 349
- References
- 52
- Citations by year
- 2026: 19 · 2025: 20 · 2024: 20 · 2023: 10 · 2022: 36 · 2021: 32 · 2020: 31 · 2019: 31 · 2018: 34 · 2017: 33 · 2016: 30 · 2015: 22 · 2014: 18 · 2013: 11
- FWCI
- 24.96
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- Locations
- Journal of Nutrition (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Clasado Ltd
- Topics
- Health Sciences › Nursing › Nutrition and Dietetics › Microbial Metabolites in Food Biotechnology
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
- Life Sciences › Agricultural and Biological Sciences › Food Science › Probiotics and Fermented Foods
- Keywords
- galactooligosaccharides, prebiotics, metabolic syndrome, overweight adults, gut microbiota, secretory IgA, calprotectin, C-reactive protein, inflammation, insulin, lipid metabolism, cholesterol, triglycerides, TC/HDL-C ratio, immune function
- MeSH terms
- Adult, Bacteria, Bifidobacterium, C-Reactive Protein, Double-Blind Method, Feces, Female, Galactose, Humans, Immunoglobulin A, Immunity, Inflammation, Insulin, Lipids, Male, Middle Aged, Oligosaccharides, Risk Factors, Biomarkers, Cross-Over Studies, Metabolic Syndrome, Leukocyte L1 Antigen Complex, Overweight, Metagenome, Prebiotics
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
